Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA meeting on Bristol-Myers Squibb diabetes drug has implications for industry
FDA meeting on Bristol-Myers Squibb diabetes drug has implications for industry
FDA meeting on Bristol-Myers Squibb diabetes drug has implications for industry
Submitted by
admin
on April 1, 2009 - 7:16am
Source:
Yahoo/AP
News Tags:
FDA
diabetes
Bristol-Myers Squibb
Onglyza
GSK
AstraZeneca
Headline:
FDA meeting on Bristol-Myers Squibb diabetes drug has implications for industry
Do Not Allow Advertisers to Use My Personal information
